Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNMT1 | P26358 | 6/20 | 0.63 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.63 |
| ▸ | DNMT3B | Q9UBC3 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | PNP | P00491 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.49 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | TK1 | P04183 | 2/20 | 0.48 |
| ▸ | FPR2 | P25090 | 1/20 | 0.48 |
| ▸ | TK2 | O00142 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28116379 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL19657171 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL14450224 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL27370160 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL5983910 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL30616797 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL5953088 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL844010 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| SCHEMBL20466819 | 1.00 | DNMT1 (0.63) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL5709929 | 0.99 | DNMT1 (0.62) | DNMT1ADRB1DNMT3BLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5144 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260117285-A1 | COMPOSITIONS AND METHODS FOR IMPROVING LIBRARY ENRICHMENT | ILLUMINA INC (US) | 2026-04-30 | — | — | US | claimed |
| EP-4229216-B1 | DETECTION AND ANALYSIS OF STRUCTURAL VARIATIONS IN GENOMES | UNIV LELAND STANFORD JUNIOR (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4689108-A1 | SMAD7 INHIBITORY ANTISENSE OLIGONUCLEOTIDES (ASO) FOR TREATING POUCHITIS AND METHODS OF USING THE SAME | Nogra Pharma Limited (IE) | 2026-02-11 | — | — | EP | claimed |
| US-12503720-B2 | Multiplexed profiling of RNA and DNA modifications | Alida Biosciences Inc. (US) | 2025-12-23 | — | — | US | claimed |
| EP-4649153-A1 | MODIFIED MULTI-SEGMENTED ANTISENSE OLIGONUCLEOTIDES FOR USE | Ausperbio Therapeutics Inc. (US) | 2025-11-19 | — | — | EP | claimed |
| WO-2025224162-A1 | NOVEL RECOMBINANT TET3 ENZYMES | QUGEN GMBH (DE) | 2025-10-30 | — | — | WO | claimed |
| EP-4640827-A1 | RECOMBINANT TET3 ENZYMES | Ludwig-Maximilians-Universität München (DE) | 2025-10-29 | — | — | EP | claimed |
| US-20250263678-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF RNA | REJUVENATION TECHNOLOGIES, INC. (US) | 2025-08-21 | — | — | US | claimed |
| US-20250263794-A1 | RNA AND DNA ANALYSIS USING ENGINEERED SURFACES | ALIDA BIOSCIENCES, INC. (US) | 2025-08-21 | — | — | US | claimed |
| US-20250250634-A1 | RNA AND DNA ANALYSIS USING ENGINEERED SURFACES | ALIDA BIOSCIENCES, INC. (US) | 2025-08-07 | — | — | US | claimed |
| US-5763208-A | Oligonucleotides and their analogs capable of passive cell membrane permeation | GILEAD SCIENCES, INC. (US) | 1998-06-09 | — | — | US | claimed |
| WO-1998004575-A2 | LIPOPHILIC OLIGONUCLEOTIDE ANALOGS | GILEAD SCIENCES, INC. (US) | 1998-02-05 | — | — | WO | claimed |
| EP-0801684-A1 | PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS | Novartis AG (CH) | 1997-10-22 | — | — | EP | claimed |
| US-5633360-A | CONTAINS AT LEAST TWO NUCLEOSIDE RESIDUES AND INTERNUCLEOTIDE LINKAGES | GILEAD SCIENCES, INC. (US) | 1997-05-27 | — | — | US | claimed |
| WO-1996024683-A1 | PROCESS FOR THE COMPLETE REMOVAL OF PROTECTIVE GROUPS ON NUCLEOSIDE DIPHOSPHATE AND TRIPHOSPHATE SUGARS | NOVARTIS AG (CH) | 1996-08-15 | — | — | WO | claimed |
| US-5407801-A | Forming linker arm by bisulfite-catalyzed transamination at specific deoxycytidine site; hybridizing duplex to triplex | THE JOHNS HOPKINS UNIVERSITY (US) | 1995-04-18 | — | — | US | claimed |
| EP-0450370-A1 | Branch migration of nucleotides | ENZO BIOCHEM, INC. (US) | 1991-10-09 | — | — | EP | claimed |
| EP-0258412-A1 | COMPOSITION FOR AND METHOD OF TREATING AIDS AND CERTAIN RELATED DISEASES | GREER, Sheldon B. (US) | 1988-03-09 | — | — | EP | claimed |
| WO-1987004929-A1 | COMPOSITION FOR AND METHOD OF TREATING AIDS AND CERTAIN RELATED DISEASES | GREER SHELDON B | 1987-08-27 | — | — | WO | claimed |
| US-4148887-A | SUGAR ESTER WITH A METHYL SULFOXIDE | THE PROCTER & GAMBLE COMPANY (US) | 1979-04-10 | — | — | US | claimed |